This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Cooperative International Neuromuscular Research Group
ClinicalTrials.gov Identifier:
NCT01539772
First received: February 22, 2012
Last updated: January 23, 2017
Last verified: January 2017
February 22, 2012
January 23, 2017
April 2012
March 2017   (Final data collection date for primary outcome measure)
  • Strength and function [ Time Frame: Annual ]
  • Quality of life [ Time Frame: Annual ]

    These questionnaires include:

    • Pediatric Quality of Life Inventory (PedsQL)
    • Pediatrics and Adult Neuromuscular module Quality of Life (NeuroQOL)
  • Medical history assessment - ambulation status, medication history, hospitalizations, surgeries, nutrition, fractures, and cardiac tests [ Time Frame: Annual ]
Not Provided
Complete list of historical versions of study NCT01539772 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping
PITT0112: Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping
This is a multi-center natural history study that will be conducted at participating centers in the Cooperative International Neuromuscular Research Group (CINRG). Following a baseline evaluation, participants will have three follow-up visits over a three-year period. The investigators will characterize the Becker muscular dystrophy phenotype, and correlate specific abnormal dystrophin proteins with the range of clinical outcomes.
We will utilize the Cooperative International Neuromuscular Research group (CINRG) network to collect cohorts of Becker muscular dystrophy (BMD) patients with in-frame deletions in the dystrophin gene. We will collect clinical data across multiple body systems and correlate these findings to the high-resolution deletion break-point mapping performed from the tissue samples. We will investigate the observed variability to deepen our understanding of molecular mechanisms relevant to the optimization of exon skipping therapeutic approaches.
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
BMD participants over 4 years of age with in-frame deletions in the dystrophin gene.
Becker Muscular Dystrophy
Not Provided
Becker

BMD participants over 4 years of age with in-frame deletions in the dystrophin gene.

Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
85
March 2017
March 2017   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Male
  • Age 4 or older
  • Diagnosis of BMD with an in-frame deletion in the dystrophin gene, where the boundaries of the mutations are confirmed.

Exclusion Criteria:

• Investigator assessment of inability to comply with protocol

Sexes Eligible for Study: Male
4 Years and older   (Child, Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Canada,   Italy,   United Kingdom,   United States
Argentina,   Israel
 
NCT01539772
PITT0112
Yes
Not Provided
Not Provided
Cooperative International Neuromuscular Research Group
Cooperative International Neuromuscular Research Group
Not Provided
Study Chair: Paula R Clemens, MD University of Pittsburgh
Cooperative International Neuromuscular Research Group
January 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP